Dioseve Inc.
PrivateLast Round
Series A
Extension
Jun 16, 2026
Total Funding Raised
$17M
Momentum
Top 5%
of companies Caplight tracks
Company Overview
Dioseve Inc. operates in Healthcare & Life Sciences and is based in Tokyo. Its latest recorded funding round was a Series A Extension round in June 2026.
Dioseve Inc. is a biotechnology company that develops assisted reproductive technology using oocytes and ovarian somatic cells derived from induced pluripotent stem (iPS) cells.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Non-AI
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Dioseve Inc. Comparables
Compare Dioseve Inc. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Conception | 87% | |
| Ivy Natal | 86% | |
| Vitra Labs | 84% |
For institutional investors. Book with your work email.
Dioseve Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A Extension | Jun 16, 2026 | ||||
| Series A | Jun 27, 2024 | ||||
| Seed | Aug 18, 2022 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Dioseve Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Coral Capital | Seed |
| Shionogi & Co. | Series A Extension |
| D4V (Design for Ventures) | Series A Extension |
| Hokuriku Region Venture Fund | Series A |
| DG Daiwa Ventures | Series A Extension, Series A |
| ANRI株式会社 | Series A, Seed |
| Miraidoa | Series A Extension, Series A |
For institutional investors. Book with your work email.
Market signals
Structured signals derived from secondary market and firmographic data.
- Jun 17, 2026
Led by Shionogi & Co.
- Apr 1, 2026
Assisted reproductive technology using iPS cells has entered the clinical research phase.
For institutional investors. Book with your work email.
Dioseve Inc. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Dioseve Inc.'s valuation, stock price, and market status.
Is Dioseve Inc. a public or private company?
Dioseve Inc. is a private company.
What is the current stock price of Dioseve Inc.?
Dioseve Inc. is a private company, so its shares have no public market price. Caplight tracks Dioseve Inc.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Dioseve Inc. worth (valuation)?
Valuation information for Dioseve Inc. is not publicly available.
Can I buy Dioseve Inc. stock?
Dioseve Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Dioseve Inc.'s last funding round?
Dioseve Inc.'s most recent funding round was Series A Extension on June 16, 2026.
Who are the main investors in Dioseve Inc.?
Key investors in Dioseve Inc. include Shionogi & Co., ANRI株式会社, Spiral Capital, Archetype Ventures.
Will Dioseve Inc. IPO soon?
No public IPO plans have been announced for Dioseve Inc..
How can I track Dioseve Inc. secondary market activity?
Caplight tracks bids, offers, and trades in Dioseve Inc.'s shares on secondary markets.